Professor and Founding Chairman of Surgery
General Surgery
Dr. Eddie K. Abdalla, MD
|
|
Give Review
Eddie K. Abdalla, MD practices General Surgery. He studied medicine at University of Michigan Medical School. He has 11 awards "Most Compassionate Doctor Award", "Who's Who Among Executives and Professionals, Heritage", "America's Top Surgeons Award", "Madison Who's Who in America", "Marquis Who's Who in America", "Patients' Choice Award", "Top Doctors", "Teacher of the Year Award", "Summer Internship Students Teacher Award", "Clinical Excellence Award" and "Fellow (FACS)". Eddie K. Abdalla, MD is a published doctor and has 98 publications published. The lastest was: 'Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer.'
Publications
- Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast Cancer.
- Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.
- Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors.
- Margin Status Remains an Important Determinant of Survival After Surgical Resection of ColoRectal Liver Metastases in the Era of Modern Chemotherapy.
- Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case-Control Analysis.
- Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: Analysis of 5651 National Surgical Quality Improvement Program patients.
- Neither Neoadjuvant nor Adjuvant Therapy Increases Survival After Biliary Tract Cancer Resection with Wide Negative Margins.
- Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy.
- Effect of Neoadjuvant Chemoradiation and Surgical Technique on Recurrence of Localized Pancreatic Cancer.
- Clinical and prognostic implications of plasma insulin-like growth factor-1 and Vascular endothelial growth factor in patients with hepatocellular carcinoma.
- I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score.
- Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors.
- Radiation treatment outcomes for unresectable hepatocellular carcinoma.
- Post-therapy pathologic stage and survival in patients with pancreatic Ductal adenocarcinoma treated with neoadjuvant chemoradiation.
- Improved survival after resection of liver and lung coloRectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic dis...
- Is resection of coloRectal liver metastases after a second-line chemotherapy regimen justified?
- High survival rate after two-stage resection of advanced coloRectal liver metastases: response-based selection and complete resection define outcome.
- Resection of coloRectal liver metastases.
- Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome.
- Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for coloRectal liver me...
- Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic coloRectal metastases.
- Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic Cancer treated with neoadjuvant chemoradiation.
- Surgical strategies for synchronous coloRectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.
- Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal Cancer liver metastases.
- Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: Analysis of 1,557 consecutive liver ...
- Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for coloRectal liver metastases.
- The international position on laparoscopic Liver surgery: The Louisville Statement, 2008.
- Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic Liver volumetry.
- Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional Analysis.
- Commentary: Radiofrequency ablation for coloRectal liver metastases: do not blame the biology when it is the technology.
- Association between hypoThyroidism and hepatocellular carcinoma: a case-control study in the United States.
- Curable metastatic colorectal Cancer: recommended paradigms.
- A marking technique for intraoperative localization of small Liver metastases before systemic chemotherapy.
- Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.
- Portal vein embolization in hilar cholangiocarcinoma.
- Long-term survival after multidisciplinary management of resected Pancreatic adenocarcinoma.
- Blood neutrophil-to-lymphocyte ratio predicts survival in patients with coloRectal liver metastases treated with systemic chemotherapy.
- Hepatic resection for gastroIntestinal stromal tumor liver metastases.
- A proposed staging system for intrahepatic cholangiocarcinoma.
- Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic coloRectal metastases.
- Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal Cancer liver metastases.
- Extrahepatic Bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival ...
- Is embolization of segment 4 portal Veins before extended right hepatectomy justified?
- Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of coloRectal liver metastases.
- Aggressive combined modality therapy for recurrent colorectal Cancer involving the duodenum and pancreas: a report of 5 cases.
- Re: Right hepatic trisectionectomy for hepatoBiliary disease: results and an appraisal of its current role.
- One hundred years after "carcinoid": epidemiology of and prognostic factors for Neuroendocrine tumors in 35,825 cases in the United States.
- Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma.
- Borderline resectable pancreatic Cancer: the importance of this emerging stage of disease.
- Treatment of large and advanced hepatocellular carcinoma.
- Comparison of two methods of future Liver remnant volume measurement.
- Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for coloRectal liver metastases.
- Simultaneous resections of colorectal Cancer and synchronous liver metastases: a multi-institutional analysis.
- Systemic chemotherapy and two-stage hepatectomy for extensive bilateral coloRectal liver metastases: perioperative safety and survival.
- Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center Analysis.
- The development and characterization of a human midgut carcinoid cell line.
- Steatosis as a risk factor in Liver surgery.
- Patient selection and outcome of hepatectomy for noncoloRectal non-neuroendocrine liver metastases.
- Impact of resection status on pattern of failure and survival after Pancreaticoduodenectomy for Pancreatic adenocarcinoma.
- High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.
- Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.
- Outcomes of Liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
- Comparison of CT methods for determining the fat content of the Liver.
- Delayed recovery after pancreaticoduodenectomy: a major factor impairing the deLivery of adjuvant therapy?
- Liver hanging maneuver for large or recurrent right upper quadrant tumors.
- New paradigm in the management of liver-only metastases from colorectal Cancer.
- Resection of hepatic coloRectal metastases involving the caudate lobe: perioperative outcome and survival.
- Improving resectability of hepatic coloRectal metastases: expert consensus statement.
- Extrahepatic bile duct resection: standard treatment for advanced gallbladder Cancer?
- Results of a single-center experience with resection and ablation for sarcoma metastatic to the Liver.
- Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous Disease.
- ColoRectal metastases: resect or ablate?
- Solitary coloRectal liver metastasis: resection determines outcome.
- Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic coloRectal metastases.
- Debunking dogma: surgery for four or more coloRectal liver metastases is justified.
- Comparison between hepatic wedge resection and anatomic resection for coloRectal liver metastases.
- Unresectable hepatic coloRectal metastases: need for new surgical strategies.
- Pancreaticoduodenectomy after placement of endoBiliary metal stents.
- Staging of hepatocellular carcinoma.
- Tumor size predicts Vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma.
- Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic Liver using saline-linked cautery and ultrasonic dissection.
- Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care.
- Feasibility of a randomized trial of extended lymphadenectomy for pancreatic Cancer.
- Effect of surgical margin status on survival and site of recurrence after hepatic resection for coloRectal metastases.
- Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study.
- Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.
- Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
- Focus on treatment of large hepatocellular carcinoma.
- Liver transplantation for hepatocellular carcinoma: need for a new patient selection strategy.
- Hepatitis serology predicts tumor and Liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma.
- TransDiaphragmatic radiofrequency ablation of liver tumors.
- Staging and preoperative evaluation of upper gastroIntestinal malignancies.
- Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for coloRectal liver metastases.
- Is extended hepatectomy for hepatoBiliary malignancy justified?
- Hepatic Vascular occlusion: which technique?
- Total and segmental Liver volume variations: implications for Liver surgery.
Schools
Univ Of Mi Med Sch
University Fla
Shands Hospital University Fla
University Texas MD Anderson Cancer Center
Procedures Preformed
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- Thoracentesis
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Most Compassionate Doctor Award
- Who's Who Among Executives and Professionals, Heritage
- America's Top Surgeons Award
- Madison Who's Who in America
- Marquis Who's Who in America
- Patients' Choice Award
- Top Doctors
- Teacher of the Year Award
- Summer Internship Students Teacher Award
- Clinical Excellence Award
- Fellow (FACS)
Education
-
University of Florida -
University of Michigan Medical School -
The University of Michigan
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Similar Doctors
|
|
Dr. Merrick I. Ross, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip Yosowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aquileo N. Hernandez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice N. Cormier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vadim Sherman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Voravit Wongsa, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Rick Q. Ngo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Vollero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter D. De Ipolyi, MD |
|
|
Dr. Brian Bednarski, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter J. Curtis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramesh K. Srungaram, MD |
|
|
Dr. Courtney J. El, MD |
|
|
Dr. Phillip A. Letourneau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hector I. Saucedo Crespo, MD
This Doctor is OpenDoctor Recommended.
|